Prezzo di chiusura
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
11,61 CNY | +2,38% | +16,92% | -12,11% |
Attività
Numero di dipendenti: 1 129
Vendite per attività
CNY in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Liver Disease
28,8
%
| 180 | 23,6 % | 235 | 28,8 % | +30,45% |
Cardiovascular and Cerebrovascular
20,3
%
| 191 | 25,0 % | 166 | 20,3 % | -13,34% |
Antibacterial
18,6
%
| 84 | 11,0 % | 152 | 18,6 % | +80,96% |
Other
11,5
%
| 55 | 7,2 % | 94 | 11,5 % | +71,84% |
Gout
11,3
%
| 72 | 9,4 % | 92 | 11,3 % | +28,86% |
Fees for Technical Services
4,3
%
| 32 | 4,2 % | 35 | 4,3 % | +9,85% |
Prostaglandin
3,2
%
| 19 | 2,5 % | 26 | 3,2 % | +38,87% |
Nervous System
1,5
%
| 123 | 16,1 % | 13 | 1,5 % | -89,84% |
High-end Fluorine
0,3
%
| 2 | 0,3 % | 2 | 0,3 % | -10,64% |
Anti-tumor
0,2
%
| 3 | 0,3 % | 2 | 0,2 % | -33,75% |
Vendite per regione
CNY in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
International
61,0
%
| 438 | 57,3 % | 498 | 61,0 % | +13,64% |
China
39,0
%
| 326 | 42,7 % | 319 | 39,0 % | -2,33% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Zhi Guo Zheng
CEO | Chief Executive Officer | 53 | 15/12/14 |
Ding Min Zhu
DFI | Director of Finance/CFO | 57 | 02/11/21 |
Hua Dong Zhang
BRD | Director/Board Member | 47 | 14/12/14 |
Tuan Tuan Wang
IRC | Investor Relations Contact | - | - |
Xiao Chen Ying
SEC | Corporate Secretary | 43 | 25/12/21 |
Yu Zhong
PRN | Corporate Officer/Principal | 62 | 15/07/20 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Fei Chen
BRD | Director/Board Member | 44 | 08/01/15 |
Zhi Guo Zheng
CEO | Chief Executive Officer | 53 | 15/12/14 |
Bing Liu
FOU | Founder | 55 | 14/12/14 |
Hua Dong Zhang
BRD | Director/Board Member | 47 | 14/12/14 |
Shi Lan Zheng
BRD | Director/Board Member | 49 | 14/12/14 |
Yu Liu
BRD | Director/Board Member | 42 | 15/12/14 |
Fu Li Zhang
BRD | Director/Board Member | 56 | 13/12/17 |
He Min Zhu
BRD | Director/Board Member | 37 | 01/01/13 |
Ming Min Luo
BRD | Director/Board Member | 51 | 13/12/20 |
Guan Neng Yu
BRD | Director/Board Member | 37 | 01/01/13 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 593 069 389 | 237 411 769 ( 40,03 %) | 0 | 40,03 % |
Coordinate società
Zhejiang Ausun Pharmaceutical Co., Ltd.
5 Donghai Fourth Avenue Linhai Park
317016, Taizhou
+
http://www.ausunpharm.comSettore
Vendite per attività
Vendite per regione
Revisioni EPS
Utili annuali - Indice di sorpresa
Variaz. 1 gen. | Capi. | |
---|---|---|
-12,11% | 951 Mln | |
+26,40% | 681 Mrd | |
+21,54% | 556 Mrd | |
-5,08% | 361 Mrd | |
+17,20% | 325 Mrd | |
+5,14% | 285 Mrd | |
+13,98% | 235 Mrd | |
+4,23% | 199 Mrd | |
-11,37% | 189 Mrd | |
-3,96% | 157 Mrd |
- Borsa valori
- Azioni
- Azione 603229
- Società Zhejiang Ausun Pharmaceutical Co., Ltd.